We are live on ! Find out more
FGI

Foresight Global Investors Portfolio holdings

AUM $154M
1-Year Est. Return 26.15%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+26.15%
3 Year Est. Return
+62.89%
5 Year Est. Return
10 Year Est. Return
AUM
$203M
AUM Growth
+$28.7M
Cap. Flow
+$19.5M
Cap. Flow %
9.61%
Top 10 Hldgs %
77.86%
Holding
47
New
8
Increased
15
Reduced
6
Closed
8

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$17.7M
2
NVS icon
Novartis
NVS
+$6.71M
3
SONY icon
Sony
SONY
+$4.43M
4
TECK icon
Teck Resources
TECK
+$3.71M
5
MUFG icon
Mitsubishi UFJ Financial
MUFG
+$3.52M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$17.4M
2
DEO icon
Diageo
DEO
+$3.59M
3
TS icon
Tenaris
TS
+$2.2M
4
LHX icon
L3Harris
LHX
+$1.41M
5
ABT icon
Abbott
ABT
+$1.3M

Sector Composition

Rank Sector Weight
1 Technology 24.13%
2 Healthcare 22.15%
3 Energy 21.88%
4 Financials 18.63%
5 Industrials 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAP icon
1
SAP
SAP
$199B
$22.1M 10.88%
113,328
+14,550
+15% +$2.58M
SONY icon
2
Sony
SONY
$131B
$20.7M 10.19%
1,206,590
+240,855
+25% +$4.43M
NVO
3
Novo Nordisk
NVO
$220B
$19.1M 9.41%
+148,850
New +$17.7M
NVS icon
4
Novartis
NVS
$300B
$19.1M 9.4%
197,375
+65,400
+50% +$6.71M
SDRL icon
5
Seadrill
SDRL
$2.73B
$17.5M 8.6%
347,360
+29,346
+9% +$1.33M
CM icon
6
Canadian Imperial Bank of Commerce
CM
$108B
$15.1M 7.45%
298,191
-11,850
-4% -$560K
TS icon
7
Tenaris
TS
$28.6B
$13.8M 6.81%
352,412
-63,450
-15% -$2.2M
BP icon
8
BP
BP
$110B
$11.6M 5.71%
307,647
+35,075
+13% +$1.26M
HDB icon
9
HDFC Bank
HDB
$119B
$11.4M 5.6%
406,582
+97,860
+32% +$2.77M
CNI icon
10
Canadian National Railway
CNI
$78.2B
$7.76M 3.82%
58,900
-4,525
-7% -$578K
TECK icon
11
Teck Resources
TECK
$29B
$4.23M 2.08%
+92,300
New +$3.71M
MUFG icon
12
Mitsubishi UFJ Financial
MUFG
$260B
$3.72M 1.83%
+363,900
New +$3.52M
RIO icon
13
Rio Tinto
RIO
$148B
$1.95M 0.96%
30,670
+10,000
+48% +$670K
BRK.B icon
14
Berkshire Hathaway Class B
BRK.B
$1.07T
$1.72M 0.84%
4,081
JPM icon
15
JPMorgan Chase
JPM
$945B
$1.62M 0.8%
8,070
XOM icon
16
ExxonMobil
XOM
$639B
$1.55M 0.76%
13,341
+1,425
+12% +$149K
V icon
17
Visa
V
$689B
$1.55M 0.76%
5,555
+635
+13% +$175K
CTVA icon
18
Corteva
CTVA
$59B
$1.5M 0.74%
25,968
CASY icon
19
Casey's General Stores
CASY
$31.6B
$1.49M 0.73%
4,670
+150
+3% +$43.8K
LPLA icon
20
LPL Financial
LPLA
$26.5B
$1.47M 0.72%
5,549
BUD icon
21
AB InBev
BUD
$156B
$1.42M 0.7%
23,319
+3,300
+16% +$206K
JNJ icon
22
Johnson & Johnson
JNJ
$645B
$1.41M 0.69%
8,898
+1,300
+17% +$207K
UNP icon
23
Union Pacific
UNP
$181B
$1.4M 0.69%
5,690
ELV icon
24
Elevance Health
ELV
$81.7B
$1.37M 0.68%
2,645
IQV icon
25
IQVIA
IQV
$35B
$1.37M 0.67%
5,413

Similar funds

Foresight Global Investors's Q1 2024 Portfolio in Review

As of Q1 2024, Foresight Global Investors held 47 positions worth $203M, up 16% from $174M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Foresight Global Investors deployed $19.5M of net new capital in Q1 2024, opening 8 new positions and adding to 15 existing holdings. Its largest new stake was Novo Nordisk: 148,850 shares worth $19.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Tenaris, an estimated $2.2M trimmed.

  • Foresight Global Investors's largest Q1 2024 buy was Novo Nordisk: 148,850 shares worth $19.1M.
  • Foresight Global Investors added most to Novartis in Q1 2024, an estimated $6.71M increase.
  • Foresight Global Investors's biggest Q1 2024 reduction was Tenaris, cutting an estimated $2.2M.
  • Foresight Global Investors fully exited AstraZeneca in Q1 2024, selling an estimated $17.4M.
  • Foresight Global Investors's ten largest holdings make up 78% of its $203M portfolio in Q1 2024.
  • Foresight Global Investors opened 8 new positions and closed 8 in Q1 2024.
  • Foresight Global Investors's portfolio value rose 16% quarter-over-quarter to $203M.

Based on Foresight Global Investors's 13F filing for Q1 2024, filed 10 May 2024.